Deadline: nrx pharmaceuticals, inc. investors with substantial losses have opportunity to lead class action lawsuit - nrxp; nrxpw

San diego, california--(newsfile corp. - january 20, 2022) - the law firm of robbins geller rudman & dowd llp announces that purchasers of nrx pharmaceuticals, inc. (nasdaq: nrxp) (nasdaq: nrxpw) securities between june 1, 2021 and november 4, 2021, inclusive (the "class period") have until march 21, 2022 to seek appointment as lead plaintiff in dal bosco v. nrx pharmaceuticals, inc., no. 22-cv-00066 (d. del.). commenced on january 18, 2022, the nrx pharma class...
NRXP Ratings Summary
NRXP Quant Ranking